Daily Health Headlines

HIV Tied to Worse Hearing in Older Adults

👤by Mary Elizabeth Dallas 0 comments 🕔Monday, December 29th, 2014

FRIDAY, Dec. 26, 2014 (HealthDay News) -- A new study finds that adults with HIV tend to have worse hearing than those not infected with the AIDS-causing virus.

Researchers led by Peter Torre, of San Diego State University, assessed the hearing of 262 men averaging 57 years of age, and 134 women averaging 48 years of age. A total of 117 of the men and 105 of the women were HIV-positive.

While the study couldn't prove cause-and-effect, Torre's team found that people with HIV tended to have worse lower- and higher-frequency hearing. This was true even after the researchers took other factors into account, such as a person's long-term exposure to powerful HIV-suppressing antiviral drugs or their HIV "viral load."

"To our knowledge, this is the first study to demonstrate that HIV-positive individuals have poorer hearing across the frequency range after many other factors known to affect hearing have been controlled for," the researchers wrote.

The study "implies that HIV may have an independent effect on the inner ear," said one expert, Dr. Eric Smouha, director of otology-neurology at the Icahn School of Medicine at Mount Sinai, in New York City.

"This finding is fascinating and hopefully will be investigated further," he added. "Many adults with hearing loss have no readily identifiable cause, and this work may help identify viruses and other risk factors that escape detection now."

Dr. Darius Kohan is chief of otology and neurotology at Lenox Hill Hospital and the Manhattan Ear, Eye and Throat Hospital, both in New York City.

He said that in the study, "HIV treatment options did not seem to correlate with the hearing loss, so it is the virus itself and the body's reaction to the virus that causes the hearing deficit, not any hypothetical ear-damaging effects of antiviral therapy."

"The implication of the study is that HIV-positive patients should be carefully monitored for hearing loss and amplification provided when necessary," Kohan said. "This sensory deficit may not be preventable once patients are infected, but may be corrected with proper intervention by a hearing aid specialist."

The study is published online Dec. 26 in the journal JAMA Otolaryngology-Head & Neck Surgery.

-- Mary Elizabeth Dallas

Article Credits / Source

Mary Elizabeth Dallas / HealthDay

Mary Elizabeth Dallas wrote this story for HealthDay. HealthDay provides up to the minute breaking health news. Click here to view this full article from HealthDay.

SOURCES: Darius Kohan, M.D., chief, otology and neurotology, Lenox Hill Hospital, and the Manhattan Ear Eye and Throat Hospital, both in New York City; Eric Smouha, M.D., director, otology-neurotology, associate professor, otolaryngologydepartment of otolaryngology, Head and Neck Surgery Icahn School of Medicine at Mount Sinai, New York City; JAMA Otolaryngology-Head & Neck Surgery, news release, Dec. 26, 2014

View More Articles From Mary Elizabeth Dallas 🌎View Article Website

Sponsored Product

Lunar Sleep for $1.95

Lunar Sleep for $1.95

People who have trouble sleeping typically have low levels of melatonin, so melatonin supplements seem like a logical fix for insomnia. There is a high demand for sleep aids, especially in the U.S. The National Health Interview Survey done in 2002, and again in 2007, found 1.6 million US adults were using complementary and alternative sleep aids for insomnia. Lunar Sleep was a top choice. Use Promo Code: Sleep2014 and only pay $1.95 S&H.

Get Lunar Sleep for $1.95

More HIV Articles

Drug Combo Shows Early Promise for Remission of HIV

Drug Combo Shows Early Promise for Remission of HIV0

THURSDAY, Nov. 10, 2016 (HealthDay News) -- Animal research with an experimental two-drug therapy could hold clues for creating long-term HIV remission in people living with the virus, a new report says. The goal: to free patients from the need ...

Antibodies May Hold Key to HIV Suppression

Antibodies May Hold Key to HIV Suppression0

WEDNESDAY, Nov. 9, 2016 (HealthDay News) -- Antibodies may keep the HIV virus in check and one day let patients stop taking antiretroviral drugs, two new preliminary trials suggest. Researchers tried to quell HIV in 23 patients with infusions ...

Experimental Medicine Might Rescue People With Drug-Resistant HIV

Experimental Medicine Might Rescue People With Drug-Resistant HIV0

FRIDAY, Oct. 28, 2016 (HealthDay News) -- Researchers report that a new medication might revolutionize the treatment of HIV patients who don't respond to existing drugs. The intravenous drug, known as ibalizumab, is given every two weeks. It's ...

Study Discounts Myth of 'Patient Zero' in U.S. AIDS Crisis

Study Discounts Myth of 'Patient Zero' in U.S. AIDS Crisis0

WEDNESDAY, Oct. 26, 2016 (HealthDay News) -- Using genetic analyses of 40-year-old blood samples, scientists have arrived at a clearer understanding of the introduction and spread in North America of the virus that causes AIDS. One myth already ...

HIV May Hide in Tissues, Even After Treatment

HIV May Hide in Tissues, Even After Treatment0

WEDNESDAY, Oct. 26, 2016 (HealthDay News) -- HIV patients who've been treated with antiretroviral drugs still have the AIDS-causing virus in their tissues, a new study suggests. Treatment with antiretrovirals eliminates detectable levels of HIV ...

View More HIV Articles


Write a Comment

Your email address will not be published. Required fields are marked *

Our Mailing List

Subscribe to our mailing list to get the latest health news as it breaks!

Your information will not be shared with anyone!